-       Report 
- October 2025
-  185 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  386 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Report 
- October 2025
-  188 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- October 2025
-  195 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
           -       Report 
- October 2025
-  365 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- March 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Drug Pipelines 
- April 2025
-  60 Pages 
- Global 
   From       €1431EUR$1,600USD£1,259GBP 
      €1789EUR$2,000USD£1,574GBP 
            -       Drug Pipelines 
- April 2025
-  280 Pages 
- Global 
   From       €2147EUR$2,400USD£1,888GBP 
      €2683EUR$3,000USD£2,360GBP 
          -       Report 
- May 2025
-  110 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
            -       Report 
- October 2025
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
          -       Report 
- June 2025
-  400 Pages 
- Global 
   From       €4427EUR$4,949USD£3,894GBP 
          -       Report 
- October 2025
-  163 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- July 2022
-  165 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- August 2024
-  82 Pages 
- Japan 
   From       €3131EUR$3,500USD£2,754GBP 
          -       Report 
- November 2023
-  171 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- November 2023
-  90 Pages 
- France 
   From       €3131EUR$3,500USD£2,754GBP 
          -       Report 
- September 2022
-  60 Pages 
- Global 
   From       €1789EUR$2,000USD£1,574GBP 
          -       Report 
- January 2025
-  132 Pages 
- Global 
   From       €850EUR$950USD£747GBP 
          -       Report 
- November 2021
-  747 Pages 
- Global 
   From       €3578EUR$4,000USD£3,147GBP 
       
      Cellular Immunotherapy is a type of Immune Disorders Drugs that uses a patient's own immune cells to treat diseases. It is a form of personalized medicine that is tailored to the individual patient's needs. It works by stimulating the patient's own immune system to recognize and attack cancer cells or other diseased cells. It can also be used to treat autoimmune diseases, such as rheumatoid arthritis, lupus, and multiple sclerosis.
Cellular Immunotherapy is a rapidly growing field, with many    companies developing new treatments and technologies. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing new treatments for immune disorders. Other companies, such as Celgene, are also researching and developing new treatments for immune disorders. Additionally, many universities and research institutions are conducting research into the potential of Cellular Immunotherapy. Show Less   Read more